Primary care doctors in the UK are a “negligible” provider of commercial clinical trial activity and should be incentivised to give experimental therapies to patients.
Dr Fabrizio Calisti and Dr Thomas Thestrup of Angelini Ventures discuss how their unique medical and scientific knowledge help infuse subject matter expertise and patient insights into the
The Prescription Medicines Code of Practice Authority (PMCPA) has recently published new social media guidance to help pharma companies apply the high standards demanded by the industry's C